Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$435M |
| 2 |
Walt Disney
DIS
|
+$434M |
| 3 |
Align Technology
ALGN
|
+$429M |
| 4 |
Icon
ICLR
|
+$371M |
| 5 |
Freeport-McMoran
FCX
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.03B |
| 2 |
Amazon
AMZN
|
+$668M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$420M |
| 4 |
Microsoft
MSFT
|
+$392M |
| 5 |
Aon
AON
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.67% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 10.92% |
| 4 | Financials | 10.29% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Lennar Class A
LEN
$20.4B
| $9.08M | ﹤0.01% |
100,152
-10,310
| -9% | -$1.02M |
|
927
Afya
AFYA
$1.35B
| $9.08M | ﹤0.01% |
459,356
+2,202
| +0.5% | +$49.9K |
|
928
Dyne Therapeutics
DYN
$4.68B
| $9.07M | ﹤0.01% |
558,483
-8,683
| -2% | -$154K |
|
929
Toro Company
TTC
$8.79B
| $9.06M | ﹤0.01% |
92,981
+33,538
| +56% | +$3.66M |
|
930
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.66B
| $9.03M | ﹤0.01% |
166,591
-143,698
| -46% | -$8.27M |
|
931
Itaú Unibanco
ITUB
$89.8B
| $9.01M | ﹤0.01% |
2,347,983
-1,963,963
| -46% | -$8.04M |
|
932
Trip.com Group
TCOM
$29B
| $9M | ﹤0.01% |
292,496
-211,265
| -42% | -$6.08M |
|
|
BERY
933
DELISTED
Berry Global Group, Inc.
BERY
| $8.96M | ﹤0.01% |
160,314
+113,459
| +242% | +$6.73M |
|
|
DOC
934
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $8.94M | ﹤0.01% |
507,369
+187,956
| +59% | +$3.48M |
|
935
Ultragenyx Pharmaceutical
RARE
$2.46B
| $8.89M | ﹤0.01% |
+98,529
| New | +$8.91M |
|
936
Canadian Imperial Bank of Commerce
CM
$106B
| $8.87M | ﹤0.01% |
159,230
-43,930
| -22% | -$2.53M |
|
937
AvalonBay Communities
AVB
$27.5B
| $8.65M | ﹤0.01% |
39,057
-24,715
| -39% | -$5.55M |
|
938
Xometry
XMTR
$4.47B
| $8.65M | ﹤0.01% |
150,019
+19
| +0% | +$1.32K |
|
939
Rollins
ROL
$18.6B
| $8.57M | ﹤0.01% |
242,527
+71,279
| +42% | +$2.67M |
|
940
Mohawk Industries
MHK
$6.91B
| $8.47M | ﹤0.01% |
47,768
+8,690
| +22% | +$1.68M |
|
941
TC Energy
TRP
$70.1B
| $8.45M | ﹤0.01% |
175,760
-49,424
| -22% | -$2.4M |
|
942
Amphenol
APH
$185B
| $8.41M | ﹤0.01% |
229,714
-101,876
| -31% | -$3.74M |
|
|
HI
943
DELISTED
Hillenbrand
HI
| $8.27M | ﹤0.01% |
+193,797
| New | +$8.51M |
|
944
Corpay
CPAY
$25.7B
| $8.2M | ﹤0.01% |
31,377
-11,374
| -27% | -$2.94M |
|
|
MDLA
945
DELISTED
Medallia, Inc.
MDLA
| $8.19M | ﹤0.01% |
241,700
-1,033,296
| -81% | -$34.5M |
|
|
BNY
946
Bank of New York Mellon
BNY
$103B
| $8.17M | ﹤0.01% |
157,542
-41,485
| -21% | -$2.16M |
|
947
Invesco
IVZ
$12.4B
| $8.14M | ﹤0.01% |
337,778
-156,572
| -32% | -$3.92M |
|
948
B2Gold
BTG
$4.98B
| $8.05M | ﹤0.01% |
2,358,165
+379,202
| +19% | +$1.47M |
|
949
AGNC Investment
AGNC
$12.7B
| $7.98M | ﹤0.01% |
506,248
-342,863
| -40% | -$5.55M |
|
|
AVDL
950
DELISTED
Avadel Pharmaceuticals
AVDL
| $7.94M | ﹤0.01% |
811,257
+68,485
| +9% | +$539K |
|
Similar funds
Janus Henderson Group's Q3 2021 Portfolio in Review
As of Q3 2021, Janus Henderson Group held 2,257 positions worth $229B, down 2.1% from $234B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q3 2021 filing shows 655 new, 648 increased, 806 reduced and 67 closed positions. Its largest new stake was Ryan Specialty Holdings: 6,061,166 shares worth $205M. The largest sale was Meta Platforms (Facebook), an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2021 buy was Ryan Specialty Holdings: 6,061,166 shares worth $205M.
- Janus Henderson Group added most to Deere & Co in Q3 2021, an estimated $435M increase.
- Janus Henderson Group's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.03B.
- Janus Henderson Group fully exited Maxim Integrated Products in Q3 2021, selling an estimated $133M.
- Janus Henderson Group's ten largest holdings make up 23% of its $229B portfolio in Q3 2021.
- Janus Henderson Group opened 655 new positions and closed 67 in Q3 2021.
- Janus Henderson Group's portfolio value fell 2.1% quarter-over-quarter to $229B.
Based on Janus Henderson Group's 13F filing for Q3 2021, filed 16 Nov 2021.